Trials / Completed
CompletedNCT02643173
Hepatocellular Carcinoma Recurrence and Anesthesia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 259 (actual)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The investigators will verify the prognosis of hepatocellular carcinoma (HCC) according to the main anesthetic agents used for the general anesthesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Volatile anesthetics | |
| OTHER | Intravenous anesthetics |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2019-06-01
- Completion
- 2019-06-01
- First posted
- 2015-12-31
- Last updated
- 2019-11-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02643173. Inclusion in this directory is not an endorsement.